Prevention of stroke

Journal of Cardiovascular Risk

Volumn 8, Issue 5, 2001, Pages 257-264

  Beckett, N S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Elderly; Hypertension; Prevention; Stroke

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; RAMIPRIL;

CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; STROKE; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; GREAT BRITAIN; HUMANS; HYPERTENSION; RISK FACTORS; UNITED STATES;

EID: 0034771422     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043798-200110000-00003     Document Type: Review

References (52)

1. Stroke
2. By how much does dietary sodium reduction lower blood pressure? III - Analysis of data from trials of salt reduction
3. Case-control study of stroke and the quality of hypertension in north west England
4. Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients
5. Management of risk factors
6. Secular trends in stroke incidence and mortality. The Framingham study
7. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts
8. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials
9. Randomised trial of hypertension in elderly patients in primary care
10. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial
11. MRC trial of treatment of hypertension in older adults: Principal results
12. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension)
13. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension
14. Randomised double-blind comparison of placebo and active treatment for older patients with systolic hypertension
15. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
16. Hypertension in the elderly: Pressure to treat?
17. Drug treatment of hypertension in the elderly: A meta-analysis
18. Treatment of hypertension in the elderly
19. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension
20. Blood pressure and survival in the very old
21. Antihypertensive treatment in very old people: A subgroup meta-analysis of randomised controlled trials
22. Hypertension in the very elderly trial (HYVET): Protocol for the main trial
23. Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension
24. Diuretics, beta-blockers, and gin and tonic
25. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
26. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
27. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in old patients with hypertension-2 study
28. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
29. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
30. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
31. Major cardiovascular events in hypertensive patients randomised to doxazosin vs. chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
32. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Final results
33. Trial of secondary prevention with atenolol after transient ischaemic attack or non-disabling ischaemic stroke
34. Atenolol in secondary prevention after stroke
35. Hypotensive therapy in stroke survivors
36. Effect of antihypertensive treatment on stroke recurrence
37. Post-stroke antihypertensive treatment study. A preliminary result
38. Effect of antihypertensive treatment in patients having already suffered from stroke: Gathering the evidence
39. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
40. Tight blood pressure control and risk of macrovascular and microvascular complications in type II diabetes: UKPDS 38
41. The role of diastolic blood pressure when treating isolated systolic hypertension
42. J-shaped relation between blood pressure and stroke in treated hypertensives
43. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: Systolic Hypertension in the Elderly Program Cooperative Research Group
44. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension: Systolic Hypertension in Europe Trial Investigators
45. Chinese trial on isolated hypertension in the elderly
46. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart study
47. Total cholesterol and risk of mortality in the oldest old
48. Reduction of stroke incidence after myocardial infarction with pravastatin. The Cholesterol and Recurrent Events (CARE) Study
49. Is high serum cholesterol associated with a longer survival in elderly hypertensives?
50. Serum lipids and incidence of coronary heart disease. Findings from the systolic Hypertension in the Elderly Program (SHEP)
51. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society